News | March 10, 2015

Acute Myocardial Infarction Patient Treated with New Mechanical Thrombectomy Device

Aspire system removes thrombus occluding blood vessel in coronary arteries

Aspire, Control Medical, thrombectomy, atherectomy devices, cath lab

March 10, 2015 —George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical Thrombectomy System.

The patient presented with chest pain, nausea and shortness of breath. An angiogram was performed and showed a long segment of thrombus occluding the ramus intermedius, a blood vessel in the coronary arteries. Adams used the Aspire Mechanical Thrombectomy device to remove the thrombus, and then he was able to angioplasty and stent the artery, relieving the patient from his symptoms.

"When a patient is having an AMI, removing the thrombus in the symptomatic artery is important," said Adams. "The Aspire device allows me to remove the thrombus quickly, helping to relieve the patients symptoms."

The Aspire System allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during the procedure. Aspire Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe systems, without multiple messy and time-consuming catheter connections, disconnections and re-connections.

The patented Aspire RX-LP6 Mechanical Thrombectomy System includes an Aspire Mechanical Aspirator (drive unit/pump) and a low-profile rapid-exchange (RX) thrombectomy catheter. Mechanical aspirators are also available alone and may be connected to any thrombectomy catheter the clinician chooses to use. Control Medical also manufactures Aspire Max Mechanical Thrombectomy Systems with larger over-the-wire (OTW) thrombectomy catheters for use in the peripheral vasculature.

For more information: www.controlmedtech.com


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now